Paper4634367
Modelling of individual pharmacokinetics for computer-aided drug dosage.
Sheiner LB and 2 others. Comput Biomed Res, 1972. Cited by 270 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Modelling of individual pharmacokinetics for computer-aided drug dosage. Papers, record 4634367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4634367
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Computers | Major topic |
| Drug Therapy | Major topic |
| Models, Biological | Major topic |
| Pharmacology | Major topic |
| Adolescent | |
| Child | |
| Digoxin | |
| Dose-Response Relationship, Drug | |
| Humans | |
| Kidney Function Tests | |
| Pharmaceutical Preparations | |
| Statistics as Topic |
Source PubMed
Cited by121
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 270 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,627,441 | Model-Informed Precision Dosing in Pediatric Patients: Current Software Tools and Bedside Guided Application. | Paediatr Drugs | 2026 | https://conductscience.org/library/papers/42627441 | PubMed |
| 41,803,667 | A Machine Learning-Based Model for Individualized Prediction of Vancomycin Concentration-Time Curves in ICU Patients. | Pharmacol Res Perspect | 2026 | https://conductscience.org/library/papers/41803667 | PubMed |
| 41,105,523 | Efficacy, safety, and population pharmacokinetics of a single 1500mg dose of dalbavancin for short-term therapy in patients with chronic prosthetic joint infections. | Antimicrob Agents Chemother | 2025 | https://conductscience.org/library/papers/41105523 | PubMed |
| 40,763,305 | A Pharmacometrics-Informed Trial Simulation Framework for Optimizing Study Designs for Disease-Modifying Treatments in Rare Neurological Disorders. | CPT Pharmacometrics Syst Pharmacol | 2025 | https://conductscience.org/library/papers/40763305 | PubMed |
| 40,636,323 | Significant Predictors of Azithromycin in Population Pharmacokinetic Analysis: A Systematic Review. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/40636323 | PubMed |
| 40,461,748 | Adopting the Model Master File Framework to Enhance Modeling and Simulations Approaches for Regulatory Use. | Pharm Res | 2025 | https://conductscience.org/library/papers/40461748 | PubMed |
| 40,021,573 | Estimation of Ganciclovir Exposure in Adults Transplant Patients by Machine Learning. | AAPS J | 2025 | https://conductscience.org/library/papers/40021573 | PubMed |
| 38,965,175 | Mixed effect estimation in deep compartment models: Variational methods outperform first-order approximations. | J Pharmacokinet Pharmacodyn | 2024 | https://conductscience.org/library/papers/38965175 | PubMed |
| 38,931,826 | Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid Arthritis. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38931826 | PubMed |
| 38,685,692 | Why the racing industry and equestrian disciplines need to implement population pharmacokinetics: To learn, explain, summarize, harmonize, and individualize. | Drug Test Anal | 2025 | https://conductscience.org/library/papers/38685692 | PubMed |
| 38,498,098 | Population pharmacokinetic analyses of methotrexate in pediatric patients: a systematic review. | Eur J Clin Pharmacol | 2024 | https://conductscience.org/library/papers/38498098 | PubMed |
| 37,934,204 | Factors influencing methotrexate pharmacokinetics highlight the need for individualized dose adjustment: a systematic review. | Eur J Clin Pharmacol | 2024 | https://conductscience.org/library/papers/37934204 | PubMed |
| 37,777,307 | Treatment of evolving cancers will require dynamic decision support. | Ann Oncol | 2023 | https://conductscience.org/library/papers/37777307 | PubMed |
| 37,771,190 | Tutorial on model selection and validation of model input into precision dosing software for model-informed precision dosing. | CPT Pharmacometrics Syst Pharmacol | 2023 | https://conductscience.org/library/papers/37771190 | PubMed |
| 35,958,041 | THE PROHOROV METRIC FRAMEWORK AND AGGREGATE DATA INVERSE PROBLEMS FOR RANDOM PDEs. | Commun Appl Anal | 2018 | https://conductscience.org/library/papers/35958041 | PubMed |
| 35,893,785 | Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35893785 | PubMed |
| 35,523,482 | Study designs for clinical trials applied to personalised medicine: a scoping review. | BMJ Open | 2022 | https://conductscience.org/library/papers/35523482 | PubMed |
| 35,144,695 | Population pharmacokinetic analysis and dosage recommendations for digoxin in Japanese patients with atrial fibrillation and heart failure using real-world data. | BMC Pharmacol Toxicol | 2022 | https://conductscience.org/library/papers/35144695 | PubMed |
| 35,094,370 | Assessment of the predictive capability of modelling and simulation to determine bioequivalence of inhaled drugs: A systematic review. | Daru | 2022 | https://conductscience.org/library/papers/35094370 | PubMed |
| 34,342,170 | Easy and reliable maximum a posteriori Bayesian estimation of pharmacokinetic parameters with the open-source R package mapbayr. | CPT Pharmacometrics Syst Pharmacol | 2021 | https://conductscience.org/library/papers/34342170 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4634367
GET https://conductscience.org/api/papers/v1/4634367/cited_by?page=2